ReviewFrontiers in reproductive health2026
Association of admission C-reactive protein levels and histological chorioamnionitis in patients with preterm premature rupture of membranes: a systematic review and meta-analysis.
Review in Frontiers in reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preterm premature rupture of membranes (PPROM) is a high-risk obstetric complication. Ascending infection and histological chorioamnionitis (HCA) frequently occur after membrane rupture, contributing to severe adverse maternal and fetal outcomes. Early prediction of HCA using non-invasive biomarkers allows timely clinical management, while the predictive efficacy of C-reactive protein (CRP) for subsequent HCA in PPROM patients remains inconsistent across existing studies. This meta-analysis aimed to systematically evaluate the predictive association. Methods: We systematically searched PubMed, Scopus, Web of Science and the Cochrane Library from inception to May 20, 2026 for studies on serum CRP and subsequent HCA in PPROM patients. Pooled mean differences (MD) of admission CRP concentrations were calculated using random-effects meta-analysis with results visualized via forest plots. Leave-one-out sensitivity analysis confirmed robustness. Subgroup analyses and meta-regression were applied to explore potential sources of heterogeneity. Funnel plots, combined with Egger's test and Begg's test, were used to evaluate publication bias. All statistical analyses were conducted using R software (version 4.6.0). Results: Initially, 11 studies were screened. After excluding one low-quality study, 10 studies (1,791 participants) were ultimately included. The pooled results demonstrated that PPROM patients who subsequently developed HCA exhibited higher admission CRP levels than non-HCA controls (MD = 0.439, 95% CI: 0.179-0.700), with substantial heterogeneity ( Conclusion: This meta-analysis suggests that elevated admission CRP levels are modestly correlated with subsequent HCA in PPROM populations. CRP may serve as an auxiliary indicator to assist early risk stratification; however, its clinical utility is limited by the small effect size and substantial heterogeneity across studies. Given the observational design of the included studies, these findings represent association rather than causation. Prospective cohort studies with standardized protocols are needed to confirm these results and assess the incremental value of CRP over existing clinical predictors. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261404654.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.